Publication | Closed Access

Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

Cancer ImmunosurveillanceAutoimmune DiseaseAllergySoluble Pd-l1Circulating Cd8+pd-1+ImmunologyTumor ImmunityImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorImmunosuppressionNk Cells EncloseImmunotherapyMedicine